Consumer Medicines Information

Select from our A to Z index of CMI (Consumer Medicines Information) leaflets for both prescription and over-the-counter medicines. Available as HTML, PDF and large font PDF.

Adobe Reader is required to view PDF files.
Get Adobe Reader

Print page  view as pdf  view as large format pdf

Citracal tablets®


Consumer Medicine Information

What is in this leaflet?

Each Citracal tablet contains calcium citrate 1.19 g equivalent to calcium 250 mg.

Citracal tablets are white oval tablets embossed with 250 on one side and CITRACAL on the other.

Therapeutic indications

Citracal tablets are recommended as a source of calcium. Citracal may assist in the prevention and treatment of osteoporosis, in maintaining healthy bones, decreasing bone breakdown, and to stabilise bone mass. It may be a source of calcium where there is proven calcium malabsorption and hypocalcaemia.

Dosage and Administration

Take two tablets a day or as directed by your doctor.

Contraindications and Precautions

There are few precautions regarding Citracal treatment. Citracal should not be taken where a doctor has diagnosed there is hypercalcaemia or severe hypercalciuria. It should not be taken in conjunction with tetracycline antibiotics.

Side Effects

Side effects are rare and only mild gastric disturbance has been reported.

Shelf Life

Shelf life is 3 years from date of manufacture and the expiry date is stamped on the label.

Storage

The tablets should be stored below 25°C.

Further Information Contact

Mission Pharmacal Australia Pty. Ltd.
3 York Street Sydney NSW 2000.

Published by MIMS/myDr May 2002

Consumers should be aware that the information provided by the Consumer Medicines Information (CMI) search (CMI Search) is for information purposes only and consumers should continue to obtain professional advice from a qualified healthcare professional regarding any condition for which they have searched for CMI. CMIs are provided by MIMS Australia. CMI is supplied by the relevant pharmaceutical company for each consumer medical product. All copyright and responsibility for CMI is that of the relevant pharmaceutical company. MIMS Australia uses its best endeavours to ensure that at the time of publishing, as indicated on the publishing date for each resource (e.g. Published by MIMS/myDr January 2007), the CMI provided was complete to the best of MIMS Australia's knowledge. The CMI and the CMI Search are not intended to be used by consumers to diagnose, treat, cure or prevent any disease or for any therapeutic purpose. Cirrus Media Pty Limited, its servants and agents shall not be responsible for the continued currency of the CMI, or for any errors, omissions or inaccuracies in the CMI and/or the CMI Search whether arising from negligence or otherwise or from any other consequence arising there from.

Advertisement
Advertisement
Advertisement
Advertisement
This web site is intended for Australian residents and is not a substitute for independent professional advice. Information and interactions contained in this Web site are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further, the accuracy, currency and completeness of the information available on this Web site cannot be guaranteed. Cirrus Media Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through myDr whether arising from negligence or otherwise.
See Privacy Policy and Disclaimer.